Singapore, Feb. 27 -- ZEISS Medical Technology has announced that the National Medical Products Administration (NMPA) inChinahas approved the VISUMAX800 with SMILEpro software from ZEISS for surgically treating nearsightedness, with or without astigmatism.

The latest generation of femtosecond lasers from ZEISS enters theChinamarket at a time whenmore than 10 million eyeshave been treated with ZEISS SMILE and SMILE pro worldwide, reflecting the technology's broad global momentum driven by strong adoption inAsia,Europeand the US.

The VISUMAX800 with SMILEpro software from ZEISS enables faster treatment, creating the lenticule in less than 10 seconds thanks to a faster laser pulse repetition rate of 2 MHz.Additionally, the shorter procedur...